{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:28:04Z","timestamp":1785583684899,"version":"3.56.0"},"reference-count":18,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,5,29]]},"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>VEXAS syndrome, caused by somatic <jats:italic>UBA1<\/jats:italic> mutations in haematopoietic cells, presents a complex clinical spectrum. A patient in his 70s initially exhibited urticarial vasculitis-like symptoms, leading to inconclusive dermatological investigations and varied treatments. Conflicting biopsy results prolonged the diagnostic process, highlighting the syndrome\u2019s enigmatic nature. The evolving symptoms involved cutaneous, haematological and musculoskeletal manifestations and ultimately revealed a <jats:italic>UBA1<\/jats:italic> mutation. Treatment challenges persisted, with dapsone, mycophenolate mofetil and corticosteroids showing limited efficacy. Tocilizumab, guided by multidisciplinary collaboration and genetic sequencing, yielded positive results, emphasising its promising role. The discussion explores VEXAS syndrome\u2019s multifaceted nature, its association with myelodysplastic syndrome, diagnostic complexities and varied treatment responses. Despite advances, the prognosis remains guarded. However, individually tailored approaches and continued research will lead to improved outcomes. This case report underscores the importance of interdisciplinary collaboration, heightened awareness and personalised strategies in managing VEXAS syndrome.<\/jats:p>","DOI":"10.1136\/bcr-2024-263248","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T23:45:23Z","timestamp":1749599123000},"page":"e263248","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Unravelling VEXAS syndrome: shedding light on a recently recognised medical condition"],"prefix":"10.1136","volume":"18","author":[{"given":"Syeda Sarah","family":"Raza","sequence":"first","affiliation":[{"name":"Oncology, Shifa International Hospitals Ltd, Islamabad, Islamabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9209-0116","authenticated-orcid":false,"given":"Abdullah Ahmad","family":"Orakzai","sequence":"additional","affiliation":[{"name":"Internal Medicine, Rochester General Hospital, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Salman","sequence":"additional","affiliation":[{"name":"Hematology & Oncology, Rochester General Hospital, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Bodrog","sequence":"additional","affiliation":[{"name":"Hematology & Oncology, Rochester General Hospital, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"2025082803532841000_18.6.e263248.1","first-page":"3591","article-title":"VEXAS syndrome","volume":"137","author":"Grayson","year":"2021","journal-title":"Blood"},{"key":"2025082803532841000_18.6.e263248.2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/1744666X.2023.2157262","article-title":"An update on VEXAS syndrome","volume":"19","author":"Al-Hakim","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"key":"2025082803532841000_18.6.e263248.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026834"},{"key":"2025082803532841000_18.6.e263248.4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11739-023-03193-z","article-title":"VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases","volume":"18","author":"Vitale","year":"2023","journal-title":"Intern Emerg Med"},{"key":"2025082803532841000_18.6.e263248.5","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.983939","article-title":"Vasculitis associated with VEXAS syndrome: A literature review","volume":"9","author":"Watanabe","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2025082803532841000_18.6.e263248.6","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood.2020010177","article-title":"Therapeutic options in VEXAS syndrome: insights from a retrospective series","volume":"137","author":"Bourbon","year":"2021","journal-title":"Blood"},{"key":"2025082803532841000_18.6.e263248.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021010811"},{"key":"2025082803532841000_18.6.e263248.8","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2021010714","article-title":"VEXAS: a vivid new syndrome associated with vacuoles in various hematopoietic cells","volume":"137","author":"Lytle","year":"2021","journal-title":"Blood"},{"key":"2025082803532841000_18.6.e263248.9","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jaad.2022.10.052","article-title":"Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases","volume":"88","author":"Zakine","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"2025082803532841000_18.6.e263248.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2101920"},{"key":"2025082803532841000_18.6.e263248.11","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/art.41743","article-title":"Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS","volume":"73","author":"Ferrada","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2025082803532841000_18.6.e263248.12","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaad.2022.01.042","article-title":"VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) for the dermatologist","volume":"89","author":"Sterling","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"2025082803532841000_18.6.e263248.13","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jamadermatol.2021.3344","article-title":"UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome","volume":"157","author":"Zakine","year":"2021","journal-title":"JAMA Dermatol"},{"key":"2025082803532841000_18.6.e263248.14","doi-asserted-by":"crossref","first-page":"107245","DOI":"10.1016\/j.rmed.2023.107245","article-title":"Pulmonary manifestations in VEXAS syndrome","volume":"213","author":"Casal Moura","year":"2023","journal-title":"Respir Med"},{"key":"2025082803532841000_18.6.e263248.15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.678927","article-title":"Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome","volume":"12","author":"Staels","year":"2021","journal-title":"Front Immunol"},{"key":"2025082803532841000_18.6.e263248.16","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010286"},{"key":"2025082803532841000_18.6.e263248.17","first-page":"1456","article-title":"VEXAS-Syndrome, a newly described autoinflammatory systemic disease with dermatologic manifestations","volume":"21","author":"Baur","year":"2023","journal-title":"J Dtsch Dermatol Ges"},{"key":"2025082803532841000_18.6.e263248.18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead240"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-263248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:53:38Z","timestamp":1756378418000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-263248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,10]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1136\/bcr-2024-263248"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-263248","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}